Daniel J Renouf

Daniel J Renouf

UNVERIFIED PROFILE

Are you Daniel J Renouf?   Register this Author

Register author
Daniel J Renouf

Daniel J Renouf

Publications by authors named "Daniel J Renouf"

Are you Daniel J Renouf?   Register this Author

49Publications

1282Reads

32Profile Views

Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.

Gastroenterology 2019 09 9;157(3):823-837. Epub 2019 May 9.

Department of Integrative Oncology, BC Cancer Research Centre, Vancouver, British Columbia, Canada; Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, BC, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2019.05.004DOI Listing
September 2019

Eligibility of Metastatic Pancreatic Cancer Patients for First-Line Palliative Intent nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX.

Am J Clin Oncol 2017 Oct;40(5):507-511

Division of Medical Oncology, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000193DOI Listing
October 2017

The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers.

Mol Genet Genomic Med 2017 May 12;5(3):251-260. Epub 2017 Mar 12.

Canadian Centre for Applied Research in Cancer Control (ARCC)Cancer Control ResearchBC Cancer AgencyVancouverBritish ColumbiaCanada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mgg3.281DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441418PMC
May 2017

Validation of microRNA pathway polymorphisms in esophageal adenocarcinoma survival.

Cancer Med 2017 02 11;6(2):361-373. Epub 2017 Jan 11.

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.989DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313634PMC
February 2017

Effect of Adjuvant Chemotherapy on Stage II Rectal Cancer Outcomes After Preoperative Short-Course Radiotherapy.

Clin Colorectal Cancer 2016 12 7;15(4):352-359.e1. Epub 2016 May 7.

Division of Medical Oncology, University of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2016.04.003DOI Listing
December 2016

Reasons for Underuse of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.

Clin Colorectal Cancer 2016 06 30;15(2):179-85. Epub 2015 Sep 30.

Cancer Control Research, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15330028150011
Publisher Site
http://dx.doi.org/10.1016/j.clcc.2015.09.002DOI Listing
June 2016

Impact of Weight Changes After the Diagnosis of Stage III Colon Cancer on Survival Outcomes.

Clin Colorectal Cancer 2016 Mar 26;15(1):16-23. Epub 2015 Jul 26.

Division of Medical Oncology, University of British Columbia, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2015.07.002DOI Listing
March 2016

Prophylactic versus reactive treatment of acneiform skin rashes from epidermal growth factor receptor inhibitors in metastatic colorectal cancer.

Support Care Cancer 2016 Feb 17;24(2):799-805. Epub 2015 Jul 17.

Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-015-2846-yDOI Listing
February 2016

Effect of Adjuvant FOLFOX Chemotherapy Duration on Outcomes of Patients With Stage III Colon Cancer.

Clin Colorectal Cancer 2015 Dec 6;14(4):262-8.e1. Epub 2015 Jun 6.

Division of Medical Oncology, University of British Columbia, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2015.05.010DOI Listing
December 2015

Mismatch repair status may predict response to adjuvant chemotherapy in resectable pancreatic ductal adenocarcinoma.

Mod Pathol 2015 Oct 31;28(10):1383-9. Epub 2015 Jul 31.

Division of Anatomic Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2015.89DOI Listing
October 2015

Discovery and validation of vascular endothelial growth factor (VEGF) pathway polymorphisms in esophageal adenocarcinoma outcome.

Carcinogenesis 2015 Sep 25;36(9):956-62. Epub 2015 May 25.

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre and University of Toronto, 610 University Ave, Toronto, Ontario M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgv073DOI Listing
September 2015

Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer.

Cancer Med 2015 Aug 18;4(8):1171-7. Epub 2015 Apr 18.

Division of Medical Oncology, University of British Columbia, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559028PMC
August 2015

Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma.

Am J Surg Pathol 2015 Apr;39(4):472-8

Divisions of *Anatomic Pathology #General Surgery, Vancouver General Hospital †The University of British Columbia ‡Pancreas Centre BC §Division of Medical Oncology, BC Cancer Agency, Vancouver, BC ∥Department of Pathology, Western University, London ¶Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000333DOI Listing
April 2015

Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.

Cancer 2015 Feb 20;121(4):527-34. Epub 2014 Oct 20.

Division of Medical Oncology, University of British Columbia, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29072DOI Listing
February 2015

Association between palliative resection of the primary tumor and overall survival in a population-based cohort of metastatic colorectal cancer patients.

Ann Surg Oncol 2014 Nov 24;21(12):3917-23. Epub 2014 May 24.

Division of Medical Oncology, University of British Columbia, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-014-3797-0DOI Listing
November 2014

Diagnostic value of next-generation sequencing in an unusual sphenoid tumor.

Oncologist 2014 Jun 7;19(6):623-30. Epub 2014 May 7.

Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada; Division of Oncology/Hematology/BMT, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada; Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0390DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041668PMC
June 2014

Improvements in 5-year outcomes of stage II/III rectal cancer relative to colon cancer.

Am J Clin Oncol 2013 Dec;36(6):558-64

*British Columbia Cancer Agency †St Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e318256f5dcDOI Listing
December 2013

Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma.

J Gastroenterol Hepatol 2013 Sep;28(9):1482-8

Department of Medical Oncology, Princess Margaret Hospital, Toronto, Ontario; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.12286DOI Listing
September 2013

Body mass index and body surface area and their associations with outcomes in stage II and III colon cancer.

J Gastrointest Cancer 2013 Jun;44(2):203-10

Department of Medicine, University of British Columbia, 2775 Laurel Street, Vancouver, BC, Canada V5Z 1M9.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12029-012-9472-4DOI Listing
June 2013

Incremental cost-effectiveness of the pre- and post-bevacizumab eras of metastatic colorectal cancer therapy in British Columbia, Canada.

Eur J Cancer 2012 Sep 9;48(13):1969-76. Epub 2012 Feb 9.

Canadian Centre for Applied Research in Cancer Control (ARCC), 2nd floor, BC Cancer Research Centre, 675 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980491200039
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2012.01.012DOI Listing
September 2012

Ocular toxicity of targeted therapies.

J Clin Oncol 2012 Sep 29;30(26):3277-86. Epub 2012 May 29.

University Health Network-Princess Margaret Hospital and University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.41.5851DOI Listing
September 2012

A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer.

Invest New Drugs 2012 Jun 28;30(3):1203-7. Epub 2011 Apr 28.

University Health Network-Princess Margaret Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-011-9673-xDOI Listing
June 2012

A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer.

Invest New Drugs 2012 Apr 18;30(2):779-86. Epub 2010 Dec 18.

Division of Medical Oncology and Hematology, Rm 5-708, Princess Margaret Hospital, 610 University Avenue, Toronto M5G2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-010-9611-3DOI Listing
April 2012

Survival for metastatic colorectal cancer in the bevacizumab era: a population-based analysis.

Clin Colorectal Cancer 2011 Jun 22;10(2):97-101. Epub 2011 Apr 22.

British Columbia Cancer Agency and University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2011.03.004DOI Listing
June 2011

Surgical oncology: Is PBD suitable for resectable pancreatic cancer?

Nat Rev Clin Oncol 2010 May;7(5):246-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2010.46DOI Listing
May 2010

Successes and challenges in translational research: the development of targeted therapy for gastrointestinal stromal tumours.

Clin Cancer Res 2009 Jun 9;15(12):3908-11. Epub 2009 Jun 9.

University of British Columbia and the British Columbia Cancer Agency, Vancouver, British Colombia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1622DOI Listing
June 2009

BCL-2 expression is prognostic for improved survival in non-small cell lung cancer.

J Thorac Oncol 2009 Apr;4(4):486-91

Division of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318199e03aDOI Listing
April 2009